Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
The current price of GMED is $84.77 USD — it has increased by +0.31% in the past 24 hours. Watch Globus Medical stock price performance more closely on the chart.
What is Globus Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Globus Medical stocks are traded under the ticker GMED.
Is Globus Medical stock price growing?▼
GMED stock has fallen by -3.46% compared to the previous week, the month change is a -3.77% fall, over the last year Globus Medical has showed a +19.33% increase.
What is Globus Medical market cap?▼
Today Globus Medical has the market capitalization of 9.55B
When is the next Globus Medical earnings date?▼
Globus Medical is going to release the next earnings report on May 12, 2026.
What were Globus Medical earnings last quarter?▼
GMED earnings for the last quarter are 1.28 USD per share, whereas the estimation was 1.13 USD resulting in a +12.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Globus Medical revenue for the last year?▼
Globus Medical revenue for the last year amounts to 5.88B USD.
What is Globus Medical net income for the last year?▼
GMED net income for the last year is 1.08B USD.
How many employees does Globus Medical have?▼
As of March 16, 2026, the company has 5,300 employees.
In which sector is Globus Medical located?▼
Globus Medical operates in the Health Care sector.
When did Globus Medical complete a stock split?▼
Globus Medical has not had any recent stock splits.